Search Results - "Giancola, S. E."

Prevalence of the Clostridium difficile BI/NAP1/027 strain across the United States Veterans Health Administration by Giancola, S.E., Williams, R.J., Gentry, C.A.

“…The increased incidence and severity of Clostridium difficile infection (CDI) are thought to result partly from the emergence of the hypervirulent BI/NAP1/027…”
Get full text

Evaluation of fidaxomicin usage patterns and outcomes for Clostridium difficile infection across the United States Veterans Health Administration by Giancola, S. E., Williams, R. J., Gentry, C. A.

“…Summary What is known and objective Fidaxomicin was recently approved for the treatment of Clostridium difficile infection (CDI). Limited data on its use exist…”
Get full text

Critical evaluation of ceftolozane-tazobactam for complicated urinary tract and intra-abdominal infections by Giancola, Stephanie E, Mahoney, Monica V, Bias, Tiffany E, Hirsch, Elizabeth B

“…The rise in resistant Gram-negative pathogens continues to challenge clinicians treating infections. These resistant infections have inspired the development…”
Get full text